V. M. Rodríguez

Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A99mTc-HMPAO study

V. M. Rodríguez, R. M. Andrée, M. P. Castejón, 1997, Psychiatry Research: Neuroimaging.

Pattern of use of clozapine in Spain. Variability and under-prescription

V. M. Rodríguez, J. J. Uriarte, F. J. Sanz-Fuentenebro, 2019, Revista de Psiquiatría y Salud Mental (English Edition).

Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study

V. M. Rodríguez, R. M. Andrée, M. P. Castejón, 1997, Schizophrenia Research.

Schizophrenic syndromes and clozapine response in treatment-resistant schizophrenia

P. Cuesta, M. Catalina, V. M. Rodríguez, 1998, Psychiatry Research.

Metabolic syndrome and atypical antipsychotics: Possibility of prediction and control

C. Pato, V. M. Rodríguez, J. Valverde, 2017 .

The neuroscience of creativity : a promising or perilous enterprise ?

V. M. Rodríguez, Ricardo Martí Fluxá, 2012 .

SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine.

V. M. Rodríguez, R. M. Andrée, M. P. Castejón, 1996 .

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)

C. Rojo, M. Sacristán, L. Sans, 2009, European Psychiatry.